Escrow release date set at Dec 5th, so will be interesting to see if any Medivet holders opt to cash up. I'm going to take a look at a few more around then. I think with Pie on board (have a look at their track record), a billionaire - who doesn't throw money away and the turnaround in MLA's core medical products business, this minimises downside IMO whilst Medivet provides good upside if they can even get that moving slightly.a couple more reasonable OEM announcements given MLAs margins and the SP should be well north of 10c
DYOR, IMO etc....
MLA Price at posting:
7.1¢ Sentiment: Buy Disclosure: Held